About this trial
This is a comprehensive pathophysiological study assessing various gastric functions in patients with diabetes mellitus. The investigators aim to examine the stomach with various measurement devices to gain information about its different functions and malfunctions. After the initial measurements, the examinations will be repeated after a year in each patient. Changes in the measurement values will be examined and their relations to each other and to the overall health of the patients will be investigated.
For example it is hypothesised that diabetic patients also suffering from functional dyspepsia or gastroparesis will also show some changes in the function of the pyloric muscle.
Eligibility criteria
Qualifiers
Diabetes mellitus type I or II, minimal duration of the disease 3 years, minimal duration of specific treatment (drugs, insulin) 2 years
Disqualifiers
Diabetes mellitus type II being treated with a diet only
Severe acute decompensation of diabetes (uncontrolled diabetes) necessitating hospitalization
Concomitant treatment with more than one prokinetic agent
Active treatment with opioids or a history of treatment with opioids within 12 months before enrolment
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Institute for Clinical and Experimental Medicine
Lead sponsor
Poliklinika Agel, Dopravni zdravotnictvi a.s.
Collaborator